Drug Type Small molecule drug |
Synonyms ISM-9274 |
Target |
Action inhibitors |
Mechanism CDK12 inhibitors(cyclin dependent kinase 12 inhibitors), CDK13 inhibitors(cyclin dependent kinase 13 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Solid tumor | Preclinical | United States | 08 Oct 2023 |





